Dr. Kirk Edward Cahill, MD

Dr. Cahill practices at Loyola Medicine Pediatric Mobile Health Unit in Maywood, Illinois.

Dr. Cahill's NPI, 1780032664, was assigned on June 1, 2016. Dr. Cahill graduated from University of Chicago, Pritzker School of Medicine in 2016. Dr. Cahill holds Illinois license 036148485.

Dr. Cahill's primary practice is Loyola Medicine Pediatric Mobile Health Unit, at 2160 S 1st Avenue, Maywood, IL 60153. The practice phone is (708) 216-3299.

Dr. Cahill's primary practice is Loyola Medicine Pediatric Mobile Health Unit in Maywood, Illinois. Dr. Cahill is also affiliated with Loyola University Medical Center. The medical group on file is Loyola University Medical Center. Dmand AI also links Dr. Cahill to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account. Dr. Cahill's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cahill practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Cahill's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Cahill is licensed in Illinois.

CMS data shows 689 Medicare services from Dr. Cahill across 7 procedure codes in 2024, for 155 Medicare patients. Medicare paid $41,799 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 155 Medicare patients who saw Dr. Cahill in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cahill's median patient age at 74, with 50% women.

In 2024, Dr. Cahill wrote 459 Medicare Part D claims for 50 patients. 76% of them were for generic drugs. CMS names the drug for 337 of them, across 13 drugs with 11 or more claims each, at $1,020,385 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

Dr. Cahill accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cahill as offering telehealth.

Dmand AI links 16 papers to Dr. Cahill, published from 2013 to 2023. 2015 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Azacitidine and Cell Line, Tumor. Dr. Cahill has published most often in Blood Adv. Dr. Cahill's most frequent co-authors are Ralph R. Weichselbaum, MD, Bakhtiar Yamini and Olatoyosi M. Odenike.

CMS Open Payments shows 4 general payments to Dr. Cahill from 2 drug and device companies in 2025. Consulting fees make up the largest share, 97% of the total. Eli Lilly and Company paid the most, $4,821.

Dr. Cahill graduated from University of Chicago, Pritzker School of Medicine in 2016.